169 related articles for article (PubMed ID: 35348747)
1. VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in Prostate Cancer.
Poulose N; Forsythe N; Polonski A; Gregg G; Maguire S; Fuchs M; Minner S; Sauter G; McDade SS; Mills IG
Mol Cancer Res; 2022 Jul; 20(7):1047-1060. PubMed ID: 35348747
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.
Itkonen HM; Minner S; Guldvik IJ; Sandmann MJ; Tsourlakis MC; Berge V; Svindland A; Schlomm T; Mills IG
Cancer Res; 2013 Aug; 73(16):5277-87. PubMed ID: 23720054
[TBL] [Abstract][Full Text] [Related]
3. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development.
McCall CM; Miliani de Marval PL; Chastain PD; Jackson SC; He YJ; Kotake Y; Cook JG; Xiong Y
Mol Cell Biol; 2008 Sep; 28(18):5621-33. PubMed ID: 18606781
[TBL] [Abstract][Full Text] [Related]
5. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.
Romani B; Shaykh Baygloo N; Aghasadeghi MR; Allahbakhshi E
J Biol Chem; 2015 Jul; 290(28):17380-9. PubMed ID: 26032416
[TBL] [Abstract][Full Text] [Related]
7. Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer.
Takayama KI; Suzuki T; Fujimura T; Takahashi S; Inoue S
Mol Cancer Res; 2018 May; 16(5):846-856. PubMed ID: 29378906
[TBL] [Abstract][Full Text] [Related]
8. Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail.
Kim K; Heo K; Choi J; Jackson S; Kim H; Xiong Y; An W
Mol Cell Biol; 2012 Feb; 32(4):783-96. PubMed ID: 22184063
[TBL] [Abstract][Full Text] [Related]
9. The role of tumor suppressor dysregulation in prostate cancer progression.
Dean JL; Knudsen KE
Curr Drug Targets; 2013 Apr; 14(4):460-71. PubMed ID: 23410128
[TBL] [Abstract][Full Text] [Related]
10. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
Itkonen HM; Gorad SS; Duveau DY; Martin SE; Barkovskaya A; Bathen TF; Moestue SA; Mills IG
Oncotarget; 2016 Mar; 7(11):12464-76. PubMed ID: 26824323
[TBL] [Abstract][Full Text] [Related]
12. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.
Le Rouzic E; Belaïdouni N; Estrabaud E; Morel M; Rain JC; Transy C; Margottin-Goguet F
Cell Cycle; 2007 Jan; 6(2):182-8. PubMed ID: 17314515
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.
Linn DE; Yang X; Xie Y; Alfano A; Deshmukh D; Wang X; Shimelis H; Chen H; Li W; Xu K; Chen M; Qiu Y
J Biol Chem; 2012 Jun; 287(27):22959-68. PubMed ID: 22584579
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients.
Kamigaito T; Okaneya T; Kawakubo M; Shimojo H; Nishizawa O; Nakayama J
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):18-22. PubMed ID: 24366413
[TBL] [Abstract][Full Text] [Related]
15. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
[TBL] [Abstract][Full Text] [Related]
16. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression.
Lin Y; Lu Z; Kokontis J; Xiang J
Biochem Biophys Res Commun; 2013 Jan; 430(1):289-93. PubMed ID: 23159636
[TBL] [Abstract][Full Text] [Related]
18. Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest.
Belzile JP; Abrahamyan LG; Gérard FC; Rougeau N; Cohen EA
PLoS Pathog; 2010 Sep; 6(9):e1001080. PubMed ID: 20824083
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAc transferase regulates p21 protein levels and cell proliferation through the FoxM1-Skp2 axis in a p53-independent manner.
de Queiroz RM; Moon SH; Prives C
J Biol Chem; 2022 Sep; 298(9):102289. PubMed ID: 35868563
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor KLLN inhibits tumor growth by AR suppression, induces apoptosis by TP53/TP73 stimulation in prostate carcinomas, and correlates with cellular differentiation.
Wang Y; Radhakrishnan D; He X; Peehl DM; Eng C
J Clin Endocrinol Metab; 2013 Mar; 98(3):E586-94. PubMed ID: 23386643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
